| Date Filed | Type | Description |
| 06/29/2020 |
GN
| ContextVision announces first CE marked digital pathology product |
| 06/29/2020 |
GN
| ContextVision lanserar första CE-märkta digitala patologiprodukten |
| 06/29/2020 |
GN
| ContextVision lanserer sitt første digitale patologiprodukt med CE-merking |
| 06/24/2020 |
GN
| ContextVision – Invitation to Extraordinary General Meeting 2020 |
| 06/24/2020 |
GN
| ContextVision – Kallelse till extra bolagsstämma 2020 |
| 06/12/2020 |
GN
| ContextVision - Company presentation held at SpareBank 1 Markets Webinar |
| 05/19/2020 |
GN
| ContextVision – Mandatory notification of trade – primary insider |
| 05/12/2020 |
GN
| ContextVision strengthens board with strategic healthcare competence |
| 05/07/2020 |
GN
| ContextVision Annual General Meeting |
| 05/06/2020 |
GN
| ContextVision stock-based incentive program - share transactions |
| 04/29/2020 |
GN
| ContextVision – Mandatory notification of trade – primary insider |
| 04/23/2020 |
GN
| ContextVision Sees Strongest Quarter Ever with Record Sales and Product Momentum within Digital Pathology |
| 04/23/2020 |
GN
| ContextVision med tidenes kvartalsresultat, rekordsalg og fremdrift innen digital patologi |
| 04/02/2020 |
GN
| ContextVision – Invitation to Annual General Meeting 2020 |
| 04/02/2020 |
GN
| ContextVision – Kallelse till årsstämma 2020 |
| 04/02/2020 |
GN
| ContextVision presents Annual Report 2019 |
| 04/02/2020 |
GN
| ContextVision presenterar Årsredovisning 2019 |
| 03/20/2020 |
GN
| ContextVision – Mandatory notification of trade – primary insider |
| 03/17/2020 |
GN
| ContextVision – Mandatory notification of trade – primary insider |
| 03/10/2020 |
GN
| ContextVision AB - Company presentation held in Oslo |
| 03/04/2020 |
GN
| ContextVision - invitation to company presentation |
| 02/27/2020 |
GN
| ContextVision Grows Medical Imaging Market Footprint With New Global Customers |
| 02/21/2020 |
GN
| ContextVision Sees Strong Momentum in 2019 Across Medical Imaging and Digital Pathology Sectors |
| 02/20/2020 |
GN
| ContextVision Sees Strong Momentum in 2019 Across Medical Imaging and Digital Pathology Sectors |
| 02/20/2020 |
GN
| ContextVision opplevde sterkt momentum i 2019, både innen medisinsk bildebehandling og digital patologi |
| 11/21/2019 |
GN
| ContextVision announces first digital pathology patent granted for its unique and objective data-generation method |
| 10/24/2019 |
GN
| ContextVision - Strong Q3 with solid sales, good inflow of new customers and first product in digital pathology enters beta-testing phase |
| 10/24/2019 |
GN
| ContextVision - Sterkt tredje kvartal med bra salg, god tilsig av nye kunder, samt første produkt innen digital patologi i betatest-fasen |
| 10/24/2019 |
GN
| ContextVision - Fortsatt god försäljningsutveckling, tillskott av nya kunder, samt första produkten inom digital patologi i beta-test-fas. |
| 09/12/2019 |
GN
| ContextVision – Company presentations held at Danske Bank Small Cap Day in Stockholm |
| 08/15/2019 |
GN
| ContextVision - Second quarter saw commercial release of first AI-based product, Altumira™, Digital Pathology on track and record sales |
| 08/15/2019 |
GN
| ContextVision - Q2 - kommersiell lansering av første AI-baserte produkt, Altumira ™, positiv utvikling innen digital patologi og salgsrekord |
| 02/11/2015 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/06/2015 |
SC 13G/A
| BlackRock Inc. reports a 5.6% stake in COVIDIEN ORD |
|